Gapping down
In reaction to disappointing earnings/guidance:
- DOMO -37.4%, MRC -11.6%, MDLA -10.9%, PD -7.8%, CRWD -6.3%, CDMO -5.8%, KFY -5.1%, SAIC -4.1%, FIZZ -3.2%, ZM -1%
Other news:
- AM -4.2% (attributed to block trade pricing)
- LPT -3.8% (prices 8 mln shares of common stock at $50.50 per share)
- TPTX -2.8% (prices public offering of 4,500,000 shares of common stock at a price to the public of $45.00 per share)
- QURE -2.6% (prices underwritten public offering of 4,891,305 of its ordinary shares at a public offering price of $46.00 per share)
- ZS -1.5% (CRWD sympathy)
- ALXN -1.5% (European Patent Office determined not to grant Alexion's European patent applications 3124029 and 3167888 which relate to the pharmaceutical compositions of SOLIRIS)
Analyst comments:
- BYND -3% (initiated with Underperform at DA Davidson; tgt $130)
- CAG -1.3% (downgraded to Neutral from Buy at Goldman)
- ESRT -0.8% (downgraded to Market Perform from Outperform at BMO Capital Markets)